Kin Yip Leung
Director/Board Member bei NOVOCURE LIMITED
Vermögen: 1 Mio $ am 31.03.2024
Aktive Positionen von Kin Yip Leung
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NOVOCURE LIMITED | Director/Board Member | 05.08.2011 | - |
Independent Dir/Board Member | 05.08.2011 | - |
Karriereverlauf von Kin Yip Leung
Ehemalige bekannte Positionen von Kin Yip Leung
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PERNIX THERAPEUTICS HOLDINGS INC | Director/Board Member | 21.11.2016 | 09.05.2019 |
Independent Dir/Board Member | 21.11.2016 | 09.05.2019 | |
ALBANY MOLECULAR RESEARCH, INC. | Director/Board Member | 02.11.2010 | 04.02.2016 |
Independent Dir/Board Member | 02.11.2010 | 04.02.2016 | |
DELCATH SYSTEMS, INC. | Director/Board Member | 15.09.2014 | 11.12.2014 |
Chairman | 17.09.2013 | 15.09.2014 | |
Independent Dir/Board Member | 31.03.2011 | 15.09.2014 | |
OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.05.2003 | 01.01.2010 |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Corporate Officer/Principal | 02.02.1999 | 01.04.2003 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.01.1990 | 01.02.1999 |
C-Change | Corporate Officer/Principal | - | - |
NanoMed Pharmaceuticals, Inc.
NanoMed Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services NanoMed Pharmaceuticals, Inc. developed therapeutic and diagnostic products. The company was founded by Michael Jay, Stephen Benoit and Russell J. Mumper in 2000 and was headquartered in Kalamazoo, MI. | Director/Board Member | - | - |
Ausbildung von Kin Yip Leung
The University of Texas at Austin | Undergraduate Degree |
University of Wisconsin | Graduate Degree |
Statistik
International
Vereinigte Staaten | 11 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 5 |
Corporate Officer/Principal | 4 |
Independent Dir/Board Member | 4 |
Sektoral
Health Technology | 7 |
Commercial Services | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
DELCATH SYSTEMS, INC. | Health Technology |
NOVOCURE LIMITED | Health Technology |
Private Unternehmen | 6 |
---|---|
OSI Pharmaceuticals, Inc.
OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
Curia Global, Inc.
Curia Global, Inc. Miscellaneous Commercial ServicesCommercial Services Curia Global, Inc. engages in drug research and development, and manufacturing. It offers drug delivery, drug development, analytical services, API development and manufacturing, and drug product solutions. The company was founded by Thomas E. D'Ambra on June 19, 1991 and is headquartered in Albany, NY. | Commercial Services |
NanoMed Pharmaceuticals, Inc.
NanoMed Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services NanoMed Pharmaceuticals, Inc. developed therapeutic and diagnostic products. The company was founded by Michael Jay, Stephen Benoit and Russell J. Mumper in 2000 and was headquartered in Kalamazoo, MI. | Commercial Services |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
C-Change | |
Pernix Therapeutics Holdings, Inc.
Pernix Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. Its products include treatment of migraine pain and inflammation, insomnia, and depressive disorder. It distributes products through the following brands: Treximet, Silenor, and Zohydro ER with BeadTek. The company was founded in 1996 and is headquartered in Morristown, NJ. | Health Technology |
- Börse
- Insiders
- Kin Yip Leung
- Erfahrung